Articles Tập 67 Số CĐ13-HNKH Bệnh viện 19-8 17/09/2026

FIRST-TRIMESTER PREECLAMPSIA RISK SCREENING OUTCOMES USING A COMBINED MODEL INCORPORATING PLGF AT THAI NGUYEN A HOSPITAL

Pham Thanh Loan, Tong Thi Phuong Thao, Do Thai Phuong, Ha Hai Bang, To Hai Yen, Doan Thi Hong, Hoang Thi Thanh Ha, Huynh Quang Thuan, Ho Thi Hang, Dam Thi Phuong Lan, Hoang Thi Minh
DOI: 10.52163/yhc.v67iCD13.6572
75 Views
0 Downloads
Abstract

Objectives: To evaluate the results of first-trimester preeclampsia screening using a combined model with PLGF and to describe the clinical and paraclinical characteristics of high-risk pregnant women.

Subjects and methods: A cross-sectional descriptive study was conducted on 52 pregnant women with singleton pregnancies between 11 weeks and 13 weeks 6 days of gestation, screened at Thai Nguyen A Hospital (from March to October 2025). Preeclampsia risk was determined using the FMF algorithm. Data were analyzed using SPSS 26.0 software.

Results: 17.3% of pregnant women were classified into the high-risk preeclampsia group. The high-risk group had significantly higher blood pressure and a higher rate of positive proteinuria compared to the low-risk group (p < 0.05). PLGF levels in the high-risk group tended to be lower than in the low-risk group; however, this difference was not statistically significant. All high-risk cases were predicted to have a risk of preeclampsia before 37 weeks of gestation, with 66.7% having a risk of onset before 34 weeks.

Conclusions: The first-trimester preeclampsia screening model according to the FMF algorithm using the PLGF marker showed that 17.3% of pregnant women were classified as high-risk, all of whom were at risk for preeclampsia before 37 weeks. The high-risk group had significantly higher mean blood pressure and positive proteinuria rates, while PLGF levels showed a decreasing trend but did not reach statistical significance compared to the low-risk group.

References
[1]
[1] Duley L. The global impact of pre-eclampsia and eclampsia. Semin Perinatol, 2009, 33 (3): 130-7. doi: 10.1053/j.semperi.2009.02.010 Google Scholar
[2]
[2] Poon L.C et al. The International Federation of Gynecology and Obstetrics (FIGO) initiative on pre-eclampsia: a pragmatic guide for first-trimester screening and prevention. International Journal of Gynecology & Obstetrics, 2019, 145 (S1): 1-33. doi: 10.1002/ijgo.12802 Google Scholar
[3]
[3] Levine R.J et al. Circulating angiogenic factors and the risk of preeclampsia. New England Journal of Medicine, 2004, 350 (7): 672-683. doi: 10.1056/NEJMoa031884 Google Scholar
[4]
[4] Akolekar R et al. Maternal serum placental growth factor at 11 + 0 to 13 + 6 weeks of gestation in the prediction of pre-eclampsia. Ultrasound Obstetrics Gynecology, 2008, 32 (6): 732-9. doi: 10.1002/uog.6244 Google Scholar
[5]
[5] Bộ Y tế. Quyết định số 1911/QĐ-BYT, ngày 19 tháng 4 năm 2021, về việc ban hành tài liệu “Hướng dẫn sàng lọc và điều trị dự phòng tiền sản giật”. Google Scholar
[6]
[6] Lim A.C et al. Cervical length measurement for the prediction of preterm birth in multiple pregnancies: a systematic review and bivariate meta-analysis. Ultrasound Obstetrics Gynecology, 2011, 38 (1): 10-17. doi: 10.1002/uog.9013 Google Scholar
[7]
[7] Chaemsaithong P et al. First-trimester pre-eclampsia biomarker profiles in Asian population: multicenter cohort study. Ultrasound in Obstetrics & Gynecology, 2020, 56 (2): 206-214. doi: 10.1002/uog.21905 Google Scholar
[8]
[8] O’Gorman N et al. Multicenter screening for pre-eclampsia by maternal factors and biomarkers at 11-13 weeks’ gestation: comparison with NICE guidelines and ACOG recommendations. Ultrasound in Obstetrics & Gynecology, 2017, 49 (6): 756-760. doi: 10.1002/uog.17455 Google Scholar
[9]
[9] Rolnik D.L et al. Aspirin versus placebo in pregnancies at high risk for preterm preeclampsia. New England Journal of Medicine, 2017, 377 (7): 613-622. doi: 10.1056/NEJMoa1704559 Google Scholar
[10]
[10] Akolekar R et al. Prediction of early, intermediate and late pre-eclampsia from maternal factors, biophysical and biochemical markers at 11-13 weeks. Prenat Diagn, 2011, 31 (1): 66-74. doi: 10.1002/pd.2660 Google Scholar
[11]
[11] Levine R.J et al. Circulating angiogenic factors and the risk of preeclampsia. N Engl J Med, 2004, 350 (7): 672-83. doi: 10.1056/NEJMoa031884 Google Scholar